Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;50(1):1-9.
doi: 10.1097/MLR.0b013e31822d5de9.

Variations in the use of an innovative technology by payer: the case of drug-eluting stents

Affiliations

Variations in the use of an innovative technology by payer: the case of drug-eluting stents

Andrew J Epstein et al. Med Care. 2012 Jan.

Abstract

Background: Despite receiving identical reimbursement for treating heart disease patients with bare metal stents (BMS) or drug-eluting coronary stents (DES), cardiologists' use of the new technology (DES) may have varied by patient payer type as DES diffused. Payer-related factors that differ between hospitals and/or differential treatment inside hospitals might explain any overall differences by payer type.

Objectives: To assess the association between payer and DES use and to examine between-hospital and within-hospital variation in DES use over time.

Methods: We conducted a retrospective analysis of 4.1 million hospitalizations involving DES or BMS from 2003 to 2008 Nationwide Inpatient Sample. We estimated hybrid-fixed effects logit models and calculated the adjusted within-quarter, cross-payer differences in DES use.

Results: Coronary stent patients with Medicaid or without insurance were significantly less likely to receive DES than were patients with private insurance throughout the study period. The differences fluctuated over time as the popularity of DES relative to BMS increased and decreased. The within-hospital gaps paralleled the overall differences, and were largest in Q3 2003 (Medicaid: 11.9, uninsured: 10.9% points) and Q4 2008 (Medicaid: 12.8, uninsured: 20.7% points), and smallest in Q4 2004 (Medicaid: 1.4, uninsured: 1.1% points). The between-hospital adjusted differences in DES use by payer were small and rarely significant.

Conclusions: We found substantial differences in DES use by payer within hospitals, suggesting physicians selected the new technology for patients in a manner associated with patients' payer type.

PubMed Disclaimer

Conflict of interest statement

None of the authors had any personal or financial conflicts of interest in regard to this study. The content of this article does not reflect the views of the VA or the US government.

Figures

Figure 1
Figure 1
Unadjusted Trends in DES Use by Payer, Q2 2003–Q4 2008.
Figure 2
Figure 2
Adjusted Overall Differences in DES Use Relative to Private Pay by Payer, Q2 2003–Q4 2008.
Figure 3
Figure 3
Adjusted Within-Hospital Differences in DES Use Relative to Private Pay by Payer, Q2 2003–Q4 2008.
Figure 4
Figure 4
Adjusted Between-Hospital Differences in DES Use Relative to Private Pay by Payer, Q2 2003–Q4 2008.

Similar articles

Cited by

References

    1. Bodenheimer T. High and rising health care costs. Part 2: technological innovation. Ann Intern Med. 2005;142(11):932–937. - PubMed
    1. Hurley RE, Pham HH, Claxton G. A widening rift in access and quality: growing evidence of economic disparities. Health Aff. 2005;24:w566–w576. - PubMed
    1. McWilliams JM. Health consequences of uninsurance among adults in the United States: recent evidence and implications. Milbank Q. 2009;8(2):443–494. - PMC - PubMed
    1. Doyle JJ. Health insurance, treatment and outcomes: using auto accidents as health shocks. Rev Econ Stat. 2005;87(2):256–270.
    1. Groeneveld PW, Polsky D, Yang F, Yang L, Epstein AJ. The impact of new cardiovascular device technology on health care costs. Arch Int Med. 2011 Apr;27 Epub ahead of print. - PMC - PubMed

Publication types